Atorvastatin pretreatment, ST-segment resolution and long-term prognosis for ST-segment elevation myocardial infarction with primary percutaneous coronary intervention
A single dose of atorvastatin pretreatment before primary PCI significantly improves myocardial reperfusion parameters and may be associated with long-term clinical benefits, supporting further validation in randomized trials.
Authors
- Haiyan Xu (ORCID: https://orcid.org/0000-0002-7287-9048)
- Guotong Xie
- Tiange Chen (ORCID: https://orcid.org/0000-0002-3992-6391)
- Xiaojin Gao (ORCID: https://orcid.org/0000-0002-8158-484X)
- Pei Gao (ORCID: https://orcid.org/0000-0001-8649-1290)
- Zhifang Wang (ORCID: https://orcid.org/0000-0001-9875-9725)
- Xiang Li (ORCID: https://orcid.org/0000-0002-9851-6376)
- Yan Wang (ORCID: https://orcid.org/0000-0001-8454-0802)
- Honglei Zhao
- Chao Wu (ORCID: https://orcid.org/0000-0003-3194-6969)
- Jingang Yang (ORCID: https://orcid.org/0000-0003-4242-0022)
- Yuejin Yang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Beijing Xuanwu Traditional Chinese Medicine Hospital (CN)
- Peking University Third Hospital (CN)
- Xinxiang Central Hospital (CN)
- Fu Wai Hospital (CN)
- Ping An (China)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.ijcha.2025.101808
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00